Pharmaceutical Manufacturing Insurance Checklist

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

A practical checklist to help GMP manufacturers, CDMOs and cleanroom facilities review cover, spot gaps and prepare for renewal.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

We compare quotes from leading insurers

  • Allianz
  • Aviva
  • QBE
  • RSA
  • Zurich
  • NIG

A PRACTICAL INSURANCE CHECKLIST FOR GMP & PHARMA OPERATIONS

Why You Need a Pharmaceutical Manufacturing Insurance Checklist

Pharmaceutical manufacturing insurance is rarely “one policy that covers everything”. Most GMP businesses have a layered set of risks: product liability, clinical trial or investigational product handling, contamination exposures, cleanroom property risk, cold chain stock, equipment breakdown, regulatory disruption, data integrity, cyber threats, and contractual liabilities that can change from one sponsor to the next.

The problem is that gaps often appear in the space between policies, or in the assumptions made at renewal. Your business evolves: new product types, expanded territories, different contract structures, new cleanroom suites, additional sites, more temperature-controlled storage, increased output, or new services like QP release, serialisation or clinical packaging. If these changes are not reflected accurately in your insurance programme, you can be underinsured or exposed to non-obvious exclusions.

This checklist is designed to help you review your programme in a structured way and prepare the underwriting information insurers typically require. It also helps you ask better questions—about limits, wording, claims triggers, and how policies interact.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Before You Start: Gather the Core Information Insurers Will Ask For

A fast and accurate quote typically depends on how clearly you can describe your operations, exposures and controls. If you’re preparing for renewal, the earlier you compile this information, the better your chances of avoiding last-minute compromises on cover.

Use the list below as a starting point. Not every item will apply to every business, but most underwriters will want clarity on the big drivers: what you manufacture/handle, where it goes, and what happens if something goes wrong.

Business & Operations Overview

  • Legal entity details and any group structure
  • Primary activities (manufacturing, fill/finish, packaging, lab testing, storage, distribution)
  • GMP licence status and oversight framework
  • Products and dosage forms (sterile, non-sterile, biologics, APIs, controlled substances)
  • Clinical vs commercial supply split
  • Key customers / sponsors and contract requirements
  • Territories supplied (UK/EU/US/Worldwide)
  • Turnover and split by activity
  • Headcount and roles (manufacturing, QA, engineering, warehouse)

Risk Controls & Governance

  • Quality management system overview (deviations, CAPA, change control)
  • Recall and crisis response procedures (including mock exercises)
  • Cold chain monitoring and excursion management
  • Supplier qualification and incoming inspection controls
  • Data integrity controls and audit trail review routines
  • Maintenance schedules for critical plant and utilities
  • Training and competency management
  • Claims / incidents history (typically 3–5 years)
CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Checklist 1: Liability Insurance (Core for Most Pharma Manufacturers)

Liability is often the most contract-driven part of a pharma programme. Sponsors and customers may require specific limits, territories, additional insured wording, and evidence of cover before onboarding. The checklist below helps you validate whether your current policies match your real-world exposure.

Product Liability & Defective Medicines

  • Are your products/dosage forms described accurately (sterile/non-sterile/biologics/API)?
  • Do territories and jurisdiction match where you supply and where claims could arise?
  • Do you need worldwide / USA/Canada extensions for certain customers?
  • Are limits aligned to customer contracts and worst-case exposure?
  • Is clinical trial / IMP activity included if you manufacture or handle investigational product?
  • Do you rely on subcontractors or contract labs, and is vicarious liability addressed?
  • Do you understand key exclusions: known defects, intentional non-compliance, punitive damages (jurisdiction-dependent)?
  • Is completed operations included, and are retroactive periods relevant?

Tip: If you are a CDMO, ensure the policy reflects your role (manufacturing/service) and any contractual allocation of responsibility with the MAH/sponsor. Underwriters need clarity on who owns the MA, who controls labelling, and who makes recall decisions.

Public Liability & Site Risks

  • Do you have visitor exposure (customer audits, inspectors, contractors) and is the site described correctly?
  • Are contractors and hot works controlled and reflected in your risk presentation?
  • Do you have off-site work (engineering visits, installation, field service) that needs cover?
  • Are property damage limits sufficient for a loss involving neighbouring premises?
  • Are you relying on pollution extensions in PL where you may need specialist environmental cover?

Employers’ Liability

  • Is headcount and payroll split correctly across manufacturing, lab, warehouse and engineering?
  • Are hazardous substance exposures reflected (COSHH, potent compounds, solvents)?
  • Do you use agency staff, temps or contractors under your control and is this addressed?
  • Do you have robust incident reporting, training and maintenance documentation (helpful for defence)?
  • Are overseas employees or travel exposures relevant?

Professional Indemnity / E&O (If You Provide Services)

  • Do you provide validation, tech transfer, QA/QC services, QP release support, or consultancy?
  • Are your service deliverables and contracts reviewed for indemnity clauses?
  • Do you need cover for “failure to perform” allegations (varies by wording)?
  • Are contractual liability and duty of care triggers clear?
  • Do you have the correct retroactive date and run-off approach for long-tail disputes?

Tip: Many pharma businesses unintentionally “sell services” (e.g., release, stability, documentation support). If it’s in your SOW, it’s worth checking whether you have PI/E&O to complement product liability.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Checklist 2: Property, Cleanrooms & Business Interruption

Property risk in pharma isn’t limited to “the building”. GMP suites, cleanroom fit-out, HVAC/HEPA systems, utilities and validation dependencies often represent a major share of site value. The largest losses are frequently driven by downtime—especially after fire, flood, escape of water, or machinery breakdown.

Buildings, Cleanrooms & Fit-Out Values

  • Are buildings sums insured based on reinstatement cost, not book value?
  • Have you included cleanroom panels, ceilings, doors, airlocks, pass-throughs and specialist finishes?
  • Do lease arrangements clearly define landlord vs tenant responsibilities?
  • Do you have high-value “hidden” costs (strip-out, decontamination, re-validation) considered in planning?
  • Have site changes (new suite, expansion, new warehouse) been declared since the last renewal?

Engineering / Machinery Breakdown

  • Is critical plant included (chillers, boilers, compressors, UPS, generators, autoclaves, HVAC)?
  • Do you have service contracts and preventative maintenance evidence?
  • Are spare parts availability and lead times understood?
  • Do you rely on a single point of failure (one chiller, one freezer bank, one line)?
  • Do alarm monitoring and out-of-hours response procedures exist and are they documented?

Business Interruption (BI) Reality Check

  • Is your indemnity period long enough for cleanroom rebuild + validation + restart?
  • Have you tested a “worst credible” recovery scenario (fire in plant room, flood in suite, water leak in ceiling void)?
  • Do you have increased cost of working options (outsourcing, temp storage, generator hire)?
  • Are your gross profit / revenue declarations accurate and updated for growth?
  • Do you have dependencies on key suppliers/utilities (power, water, gas) and are extensions needed?

Tip: BI is often under-set in pharma because the reinstatement timeline includes not only construction but also commissioning, qualification and re-validation. Underestimate this and you can run out of indemnity before recovery is complete.

Fire, Flood & Escape of Water Controls

  • Do you have a clear view of fire protection (detection, sprinklers, compartmentation, hot works controls)?
  • Are electrical inspections (EICR) and thermal imaging carried out (where appropriate)?
  • Do you have leak detection, isolation valves, and documented inspection routines?
  • Is critical equipment elevated above flood risk and are drainage/flood controls in place?
  • Are housekeeping and combustible storage controls documented?
CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Checklist 3: Stock, Cold Chain & Transit

Stock losses can be devastating in pharma because the value of a batch includes not only materials but also manufacturing time, testing, release effort, and schedule impact. Cold chain and controlled storage add complexity: temperature excursions can create “deterioration” losses even without visible damage.

Stock Values & Maximum Any One Time

  • Do you know your maximum stock at any one time (raw, WIP, finished goods)?
  • Do values spike around campaigns, dispatch windows, or end-of-quarter shipments?
  • Is stock held at third-party locations (3PLs, depots) and is it declared/covered?
  • Do you need seasonal uplift or declaration-based values?
  • Are high-value items (biologics, vaccines, controlled drugs) described correctly for insurers?

Cold Chain Deterioration Controls

  • Do you have validated packaging configurations and lane risk assessments?
  • Are alarms monitored 24/7, with response SLAs and escalation paths?
  • Do you use data loggers, calibration routines and excursion decision trees?
  • Do you have backup power (UPS/generator) for critical cold rooms/freezers?
  • Is “deterioration following breakdown” addressed in policy design where required?

Transit / Cargo

  • Are you responsible for goods in transit under Incoterms / contracts?
  • Do you ship internationally and need worldwide cargo cover?
  • Do you need temperature-controlled transit extensions?
  • Are high-risk routes, theft risk, and secure courier requirements addressed?
  • Do you have clear procedures for chain of custody and shipment documentation?

Tip: Cargo insurance should be aligned with how you actually ship (courier, freight forwarder, specialist cold chain carrier) and the point at which risk transfers contractually. Misalignment here is a common gap.

Product Recall / Withdrawal Interface

  • Do you have recall/withdrawal cover if your contracts require it?
  • Is the trigger clear (e.g., actual defect, suspected defect, regulator request) and does it match your risk profile?
  • Are recall logistics and notification costs included where needed?
  • Do you know what is not covered (often brand rehabilitation, loss of market share, or voluntary upgrades)?
  • Have you rehearsed recall procedures (mock recall) and documented learnings?
CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Checklist 4: Environmental, Cyber & Management Risk

Modern pharma operations are exposed to risks that sit outside “classic” insurance buckets. Environmental liabilities can arise from solvent and chemical handling, trade waste and drainage events. Cyber incidents can stop production, disrupt batch release, and damage data integrity. Management exposures can arise from governance, investor pressure, regulatory scrutiny and employment disputes.

Environmental & Pollution Liability

  • Do you have chemicals/solvents stored on-site (bunding, segregation, spill response)?
  • Is trade waste/effluent a meaningful risk and are drains mapped/interceptors maintained?
  • Do you manage hazardous waste streams and use licensed carriers?
  • Do you rely on public liability pollution extensions that may be limited?
  • Would specialist environmental impairment liability (EIL) provide better protection?

Cyber & Data Integrity

  • Do you rely on LIMS, ERP, MES, SCADA/BMS, or electronic batch records?
  • Are backups tested and segregated, and is disaster recovery time objective realistic?
  • Do you have MFA, privileged access controls, and patch management evidence?
  • Do you need cyber business interruption and incident response support?
  • Are you exposed to supplier cyber risk (managed service providers, cloud LIMS, logistics partners)?

Tip: For GMP businesses, “data integrity” is both a regulatory and operational issue. Cyber cover should be assessed for how it responds to downtime, system restoration, and breach response—not just data theft.

Directors & Officers (D&O) / Management Liability

  • Do directors face investor, creditor or governance exposure (especially for growth-stage CDMOs)?
  • Do you have US links (subsidiary, exports, investors) that change D&O needs?
  • Is employment practices liability relevant (HR claims, discrimination, whistleblowing)?
  • Do you have coverage for investigations where insurable (wording dependent)?
  • Are limits appropriate for the organisation size and funding profile?

Regulatory Action & Licence-Related Disruption

  • Do you understand which costs may be insurable vs not insurable?
  • Do you have recall/withdrawal cover that interfaces with regulatory action scenarios?
  • Are legal defence and crisis support options worth exploring for your risk profile?
  • Do you have a business continuity plan for site shutdown/restriction scenarios?
  • Are sponsor communications and audit readiness documented?
CALL FOR EXPERT ADVICE
GET A QUOTE NOW

A Simple Renewal Playbook for Pharma Manufacturers

Insurance works best when it’s not treated as a last-minute admin task. If you want the best terms, you need time to tell your story: what you do, how you control risk, and what has improved since last year.

Use this playbook to structure your renewal discussions and keep them focused on the issues that genuinely influence underwriting.

8–12 Weeks Before Renewal

  • Confirm current activities and forecast changes (new products, new territories, new services)
  • Update values: property, cleanrooms, plant, stock and BI gross profit
  • Collect claims and incident data with lessons learned
  • Review contracts for new insurance requirements (limits, additional insureds, waivers)
  • Identify “single points of failure” (utilities, plant, cold storage) to address in submissions

4–8 Weeks Before Renewal

  • Prepare a clear underwriter summary (what you do + risk controls + what’s changed)
  • Validate policy wordings for exclusions that matter (territory, clinical activities, recall triggers)
  • Agree target limits and deductibles aligned to your risk appetite and contracts
  • Confirm evidence of controls (maintenance, training, audits, cold chain monitoring)
  • Decide on any programme upgrades (cyber BI, environmental, recall, higher limits)

Final 1–3 Weeks

  • Review quotes and compare on wording, not just price
  • Confirm endorsements required by sponsor contracts
  • Ensure certificates and evidence documents are issued correctly
  • Document internal assumptions (values, BI period, stock peaks) for next renewal
  • Schedule a post-renewal review to address improvements and risk control investments
CALL FOR EXPERT ADVICE
GET A QUOTE NOW
Quote icon

This checklist helped us identify that our stock values and BI period didn’t reflect our growth and lead times. Insure24 guided us through the gaps and made the renewal process far less stressful.

Operations Director, GMP Manufacturing Business

FREQUENTLY ASKED QUESTIONS

+-

What insurance do pharmaceutical manufacturers typically need?

Most pharma manufacturers need a combination of product liability, public liability and employers’ liability, plus property and business interruption if they own or operate facilities. Depending on activities, additional covers may include recall/withdrawal, professional indemnity/E&O, stock and transit (including cold chain), machinery breakdown, environmental liability, cyber and management liability.

+-

Why are cleanrooms and GMP suites often underinsured?

Businesses often insure the base building but underestimate the value of cleanroom fit-out, HVAC/HEPA systems, utilities and the specialist reinstatement process. Reinstatement can involve strip-out, specialist contractors and re-validation timelines, which also affects business interruption requirements.

+-

How do I choose the right product liability limit?

Consider sponsor/customer contract requirements, territories supplied, patient exposure profile, and the potential severity of a defect scenario. Sterile injectables, hospital-administered products and wide distribution can justify higher limits. Insure24 can help align limits to contracts and realistic risk scenarios.

+-

Do I need product recall insurance?

Product liability covers third-party injury/property damage claims, but recall/withdrawal insurance is designed to pay certain operational costs of removing product from the market, such as retrieval, quarantine, disposal and relabelling—subject to policy triggers. If contracts require recall cover or your risk profile makes withdrawal costs meaningful, it’s worth exploring.

+-

What’s the biggest mistake companies make with business interruption insurance?

Underestimating the indemnity period. In pharma, recovery may require not only rebuilding but also commissioning, qualification and re-validation before production can restart. If the indemnity period is too short, the policy can stop paying before you’re back to normal operations.

+-

Can cold chain temperature excursions be insured?

Many programmes can be structured to cover deterioration or temperature excursion losses in storage and/or transit, subject to policy terms, monitoring requirements and conditions. The best approach is to align cover with your monitoring, alarm response and validation controls.

+-

Do pharma manufacturers need cyber insurance?

If you rely on digital systems for batch records, lab data, production controls, scheduling, or release processes, cyber incidents can cause major downtime and data integrity disruption. Cyber insurance can provide incident response support and, where arranged, business interruption and system restoration cover—subject to wording and security requirements.

+-

How can Insure24 help with this checklist?

We can review your activities, contracts, values and risk controls, identify common gaps, and structure a programme that fits GMP operations. We also help present your risk clearly to insurers, compare suitable markets, and align wording to your real exposures and sponsor requirements.
CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Related Blogs